References

1.  Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk : raising high-density lipoproteins cholesterol levels. Postgraduate Medical Journal 2008;84: 590-8. 

2.  O’Riordan, M.  Torcetrapib Torpedoed: Increased Risk of Mortality, Cardiovascular Events Ends Development.  http://www.medscape.com/viewarticle/548725_print, accessed August 5, 2011.

3.  Sloop GD, Fallon KB, Lipscomb G, Takei H, Zieske AW. The distribution of oxidatively-modified lysine in the human vasculature. Atherosclerosis 2000;148: 255-263.

4.  Sloop GD. A critical analysis of the role of cholesterol in atherogenesis.     Atherosclerosis 1999;142: 265-8.

5.  Sloop GD. Insights into the relationship of fatty streaks to raised atherosclerotic lesions provided by the hemorheologic-hemodynamic theory of atherogenesis. Medical Hypotheses 1998; 385-8.

6. Sloop GD, Perret RS, Brahney JS, Oalmann M. A description of two morphologic patterns of aortic fatty streaks, and a hypothesis of their pathogenesis. Atherosclerosis 1998;141: 153-60.

7.  Kensey KR, Cho YI. The Origin of Atherosclerosis. Volume 1: An Introduction to Hemodynamics. EPP Medica, 2001, p.84.

8.  Perret RS, Sloop GD. Increased peak blood velocity in association with elevated blood pressure. Ultrasound in Medicine and Biology 2000;26: 1387-91.

9.  Rader DJ, Alexander ET, Weibel GL, Billheimer GL, Rothblat CH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. The Journal of Lipid Research 50; S189-S194, 2009.

10. Sloop GD, Fallon KB, Zieske AW. Atherosclerotic plaque-like lesions in synthetic arteriovenous grafts: implications for atherogenesis. Atherosclerosis 2002;1260: 133-9.

11.  Kensey and Cho, pp. 68-73.

12.  Brown CH 3rd, Leverett LB, Lewis CW, Alfrey CP Jr, Hellums JD. Morphological, biochemical, and functional changes in human platelets subjected to shear stress. Journal of Laboratory and Clinical Medicine 1975;86:462-71.

13.  Duguid JB. The thrombogenic hypothesis and its implications. Postgraduate Medical Journal 1960;36: 226-9.

14.  Majno G, Joris I. Cells, Tissues, and Disease. Blackwell Science, 1996, pp. 634, 648.

15.  Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibrosis. Laboratory Investigation 2007;87: 858-70.

16.  Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine 1994;1: 71-81.

17.  Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proceedings of the National Academy of Science 2003;100: 4754-9.

18.  Morgan, AD.  The Pathogenesis of Coronary Occlusion.  Blackwell Scientific Publications, Oxford, p.117.

19.  Morgan, p. 84.

20.  Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clinical Science 1997;92:473-9.

21.  Kawasaki T, Kambayashi J, Ariyoshi H, Sakon M, Suehisa E, Monden M. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thrombosis Research 1997;88:67-73.

22. Sloop GD. Possible association of a reduction in cardiovascular events with blood donation. Heart 1998;79:422.

23.  Chan J, Knutsen SF, Blixx GG, Lee JW, Fraser GE. Water, other fluids, and fatal coronary heart disease: the Adventist Health Study. American Journal of Epidemiology 2002;155: 827-33.